{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:42:33Z","timestamp":1757310153365},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T00:00:00Z","timestamp":1316131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T00:00:00Z","timestamp":1316131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s11926-011-0211-9","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T09:01:38Z","timestamp":1316077298000},"page":"496-505","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neuromyelitis Optica-AQP4: An Update"],"prefix":"10.1007","volume":"13","author":[{"given":"Emilio","family":"Benavente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Paira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,16]]},"reference":[{"key":"211_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0140-6736(02)68218-2","volume":"1","author":"TC Allbutt","year":"1870","unstructured":"Allbutt TC. On the ophthalmoscopic signs of spinal disease. Lancet. 1870;1:76\u20138.","journal-title":"Lancet"},{"key":"211_CR2","first-page":"1033","volume":"8","author":"E Devic","year":"1894","unstructured":"Devic E. My\u00e9lite subaigu\u00eb compliqu\u00e9e de n\u00e9vrite optique. Bull Med (Paris). 1894;8:1033\u20134.","journal-title":"Bull Med (Paris)"},{"key":"211_CR3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology. 1999;53:1107\u201314.","journal-title":"Neurology"},{"key":"211_CR4","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485\u20139.","journal-title":"Neurology"},{"issue":"9451","key":"211_CR5","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106\u201312.","journal-title":"Lancet"},{"key":"211_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1191\/1352458503ms947oa","volume":"9","author":"J Seze","year":"2003","unstructured":"Seze J, Lebrun C, Stojkovic T, et al. Is Devic\u2019s neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler. 2003;9:521\u20135.","journal-title":"Mult Scler"},{"key":"211_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/BF00878876","volume":"242","author":"V Harisdangkul","year":"1995","unstructured":"Harisdangkul V, Doorenbos D, Subramony SH. Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol. 1995;242:326\u201331.","journal-title":"J Neurol"},{"key":"211_CR8","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.1007\/s10072-004-0342-0","volume":"25","author":"R Bergamaschi","year":"2004","unstructured":"Bergamaschi R, Ghezzi A. Devic\u2019s neuromyelitis optica: clinical features and prognostic factors. Neurol Sci. 2004;25:S364\u20137.","journal-title":"Neurol Sci"},{"key":"211_CR9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.56.4.507","volume":"56","author":"P Cabre","year":"2001","unstructured":"Cabre P, Heinzlef O, Merle H, et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology. 2001;56:507\u201314.","journal-title":"Neurology"},{"issue":"4","key":"211_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ophtha.2006.06.060","volume":"114","author":"H Merle","year":"2007","unstructured":"Merle H, Olindo S, Bonnan M, et al. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology. 2007;114(4):810\u20135. Epub 2006 Nov 30.","journal-title":"Ophthalmology"},{"issue":"4","key":"211_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/jnnp.73.4.429","volume":"73","author":"RM Papais-Alvarenga","year":"2002","unstructured":"Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry. 2002;73(4):429\u201335.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"211_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/brain\/59.3.353","volume":"59","author":"BH Balser","year":"1936","unstructured":"Balser BH. Neuromyelitis optica. Brain. 1936;59:353\u201365.","journal-title":"Brain"},{"key":"211_CR13","first-page":"146","volume":"1879\u2013","author":"W Erb","year":"1980","unstructured":"Erb W. \u00dcber das Zusammenkommen von Neuritis optica und Myelitis subacute. Arch Psychiatr Nervenkr 1879\u20131980;1:146\u201357.","journal-title":"Arch Psychiatr Nervenkr"},{"key":"211_CR14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/brain\/50.3-4.687","volume":"50","author":"GM Beck","year":"1927","unstructured":"Beck GM. A case of diffuse myelitis associated with optic neuritis. Brain. 1927;50:687\u2013703.","journal-title":"Brain"},{"key":"211_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(03)12784-5","volume":"361","author":"BG Weinshenker","year":"2003","unstructured":"Weinshenker BG. Neuromyelitis optica: what it is and what it might be. Lancet. 2003;361:889\u201390.","journal-title":"Lancet"},{"key":"211_CR16","first-page":"362","volume":"119","author":"HB Field","year":"1961","unstructured":"Field HB. A case of neuomyelitis optica. Ill Med J. 1961;119:362\u20137.","journal-title":"Ill Med J"},{"key":"211_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/archneur.63.3.390","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006;63:390\u20136.","journal-title":"Arch Neurol"},{"key":"211_CR18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/archopht.1957.00930050118020","volume":"57","author":"RJ Keefe","year":"1957","unstructured":"Keefe RJ. Neuromyelitis optica with increased intracranial pressure. Arch Ophthal. 1957;57:110\u20131.","journal-title":"Arch Ophthal"},{"key":"211_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/jnnp.60.4.382","volume":"60","author":"JI O\u2019Riordan","year":"1996","unstructured":"O\u2019Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic\u2019s neuromyelitis optica. J Neurol Neurosurg Psychiatry. 1996;60:382\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"211_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-2094-7-52","volume":"7","author":"S Jarius","year":"2010","unstructured":"\u2022 Jarius S, Franciotta D, Paul F, et al. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation 2010;7:52. In the cohort analyzed in this study, testing for CSF AQP4 antibodies did not improve the sensitivity and specificity of the current diagnostic criteria for NMO. The substantial lack of intrathecal AQP4 antibody synthesis in patients with NMOSD may reflect the unique localization of the target antigen at the blood\u2013brain barrier and is important for our understanding of the immunopathogenesis of the disease.","journal-title":"J Neuroinflammation"},{"key":"211_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/00004728-198705000-00027","volume":"11","author":"K Tashiro","year":"1987","unstructured":"Tashiro K, Ito K, Maruo Y, et al. MR imaging of spinal cord in Devic disease. J Comput Assist Tomogr. 1987;11:516\u20137.","journal-title":"J Comput Assist Tomogr"},{"key":"211_CR22","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/brain\/124.8.1509","volume":"124","author":"J de Seze","year":"2001","unstructured":"de Seze J, Stojkovic G, Breteau G, et al. Acute myelopathies. Clinical, laboratory and outcome profiles in 79 cases. Brain. 2001;124:1509\u201321.","journal-title":"Brain"},{"issue":"2","key":"211_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1055\/s-2002-36534","volume":"22","author":"B Cree","year":"2002","unstructured":"Cree B, Goodin D, Hauser S. Neuromyelitis optica. Semin Neurol. 2002;22(2):105\u201322.","journal-title":"Semin Neurol"},{"key":"211_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/1352458506070725","volume":"13","author":"J Cabrera-Gomez","year":"2007","unstructured":"Cabrera-Gomez J, Quevedo-Sotolongo, Gonzalez-Quevedo A, et al. Brain magnetic resonance imaging findings neuromyelitis optica. Mult Scler. 2007;13:186\u201392.","journal-title":"Mult Scler"},{"issue":"7","key":"211_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006;63(7):964\u20138.","journal-title":"Arch Neurol"},{"key":"211_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/BF00593340","volume":"33","author":"F Barkhof","year":"1991","unstructured":"Barkhof F, Scheltens P, Valk J, Waalewijn C, Uitdehaag BM, Polman CH. Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using gadolinium-\u201cenhanced\u201d STIR imaging. Neuroradiology. 1991;33:70\u20131.","journal-title":"Neuroradiology"},{"issue":"4","key":"211_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202(4):473\u20137. Epub 2005 Aug 8.","journal-title":"J Exp Med"},{"issue":"12","key":"211_CR28","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nrn1252","volume":"4","author":"M Amiry-Moghaddam","year":"2003","unstructured":"Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci. 2003;4(12):991\u20131001.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"211_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0022-510X(68)90031-2","volume":"6","author":"JF Kurtzke","year":"1968","unstructured":"Kurtzke JF, Park CS, Oh SJ. Multiple sclerosis in Korea. Clinical features and prevalence. J Neurol Sci. 1968;6(3):463\u201381.","journal-title":"J Neurol Sci"},{"issue":"1","key":"211_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/archneurol.2007.17","volume":"65","author":"S Pittock","year":"2008","unstructured":"Pittock S, Lennon V, de Seze, et al. Neuromyelitis optica and non-organ-specific autoimmunity. Arch Neurol. 2008;65(1):78\u201383.","journal-title":"Arch Neurol"},{"key":"211_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00041327-199712000-00008","volume":"17","author":"T Harada","year":"1997","unstructured":"Harada T, Ohashi T, Harada C, et al. A case of bilateral optic neuropathy and recurrent transverse myelopathy associated with perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA). J Neuroophthalmol. 1997;17:254\u20136.","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"211_CR32","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.54.6.1391","volume":"54","author":"A Mochizuki","year":"2000","unstructured":"Mochizuki A, Hayashi A, Hisahara S, Shoji S. Steroid-responsive Devic\u2019s variant in Sj\u00f6gren\u2019s syndrome. Neurology. 2000;54(6):1391\u20132.","journal-title":"Neurology"},{"key":"211_CR33","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s10067-010-1502-7","volume":"29","author":"S Paira","year":"2010","unstructured":"\u2022 Paira S, Benegas M, Ortiz A. Association of neuromyelitis optic (NMO) with autoimmune disorders: report of two cases and review of the literature. Clin Rheumatol 2010;29:1335\u20138. In this article, the authors present two patients with NMO (Devic disease), one associated with SLE and the other with Hashimoto\u2019s thyroiditis. They emphasize the importance of ruling out other entities throughout the follow-up. NMO is seldom described in patients with lupus, which may be due to the rare occurrence of this association, sometimes leading to its misdiagnosis.","journal-title":"Clin Rheumatol"},{"key":"211_CR34","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain. 2002;125:1450\u201361.","journal-title":"Brain"},{"key":"211_CR35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/archopht.1949.00900050298007","volume":"42","author":"FC Stansbury","year":"1949","unstructured":"Stansbury FC. Neuromyelitis optica (Devic\u2019s disease): presentation of five cases with pathologic study, and review of the literature. Arch Ophthalmol. 1949;42:292\u2013335.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"211_CR36","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","volume":"46","author":"BG Weinshenker","year":"1999","unstructured":"Weinshenker BG, O\u2019Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46(6):878\u201386.","journal-title":"Ann Neurol"},{"issue":"7","key":"211_CR37","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","volume":"64","author":"BA Cree","year":"2005","unstructured":"Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005;64(7):1270\u20132.","journal-title":"Neurology"},{"issue":"Pt 5","key":"211_CR38","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007;130(Pt 5):1194\u2013205. Epub 2007 Feb 4.","journal-title":"Brain"},{"issue":"3","key":"211_CR39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1620\/tjem.209.269","volume":"209","author":"T Misu","year":"2006","unstructured":"Misu T, Fujihara K, Nakamura M, et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med. 2006;209(3):269\u201375.","journal-title":"Tohoku J Exp Med."},{"issue":"3","key":"211_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/WCO.0b013e32814f1c6b","volume":"20","author":"M Matiello","year":"2007","unstructured":"Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Opin Neurol. 2007;20(3):255\u201360.","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"211_CR41","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/0002-9343(92)90788-D","volume":"92","author":"JT Tesar","year":"1992","unstructured":"Tesar JT, McMillan V, Molina R, Armstrong J. Optic neuropathy and central nervous system disease associated with primary Sj\u00f6gren\u2019s syndrome. Am J Med. 1992;92(6):686\u201392.","journal-title":"Am J Med"},{"key":"211_CR42","first-page":"153","volume":"12","author":"PM Williamson","year":"1975","unstructured":"Williamson PM. Neuromyelitis optica following infectious mononucleosis. Proc Aust Assoc Neurol. 1975;12:153\u20135.","journal-title":"Proc Aust Assoc Neurol"},{"key":"211_CR43","first-page":"238","volume":"38","author":"S Doutlik","year":"1975","unstructured":"Doutlik S, Sblova O, Kryl R, Novak M. Neuromyelitis optica as a parainfectious complication of varicella. Cesk Neurol Neurochir. 1975;38:238\u201342.","journal-title":"Cesk Neurol Neurochir"},{"key":"211_CR44","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0022-3476(79)80723-4","volume":"95","author":"MJ Chusid","year":"1979","unstructured":"Chusid MJ, Williamson SJ, Murphy JV, Ramey LS. Neuromyelitis optica (Devic disease) following varicella infection. J Pediatr. 1979;95:737\u20138.","journal-title":"J Pediatr"},{"key":"211_CR45","first-page":"450","volume":"240","author":"SM al-Deeb","year":"1993","unstructured":"al-Deeb SM, Yaqub BA, Khoja WO. Devic\u2019s neuromyelitis optica and varicella. J Neurol. 1993;240:450\u20131.","journal-title":"J Neurol"},{"key":"211_CR46","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp.68.6.795a","volume":"68","author":"P Blanche","year":"2000","unstructured":"Blanche P, Diaz E, Gombert B, Sicard D, Rivoal O, Brezin A. Devic\u2019s neuromyelitis optica and HIV-1 infection. J Neurol Neurosurg Psychiatry. 2000;68:795\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"211_CR47","first-page":"303","volume":"136","author":"J Barbizet","year":"1980","unstructured":"Barbizet J, Degos JD, Meyrignac C. Acute neuromyelitis optica and acute pulmonary tuberculosis (author\u2019s trans.). Rev Neurol (Paris). 1980;136:303\u20139.","journal-title":"Rev Neurol (Paris)"},{"key":"211_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/brain\/100.2.223","volume":"100","author":"RA Hughes","year":"1977","unstructured":"Hughes RA, Mair WG. Acute necrotic myelopathy with pulmonary tuberculosis. Brain. 1977;100:223\u201338.","journal-title":"Brain"},{"key":"211_CR49","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1212\/WNL.40.6.934","volume":"40","author":"MH Silber","year":"1990","unstructured":"Silber MH, Willcox PA, Bowen RM, Unger A. Neuromyelitis optica (Devic\u2019s syndrome) and pulmonary tuberculosis. Neurology. 1990;40:934\u20138.","journal-title":"Neurology"},{"issue":"1","key":"211_CR50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1212\/WNL.48.1.58","volume":"48","author":"JC Vernant","year":"1997","unstructured":"Vernant JC, Cabre P, Smadja D, et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology. 1997;48(1):58\u201364.","journal-title":"Neurology"},{"issue":"3","key":"211_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1034\/j.1600-0404.2003.02178.x","volume":"108","author":"L Fardet","year":"2003","unstructured":"Fardet L, G\u00e9n\u00e9reau T, Mikaeloff Y, Fontaine B, Seilhean D, Cabane J. Devic\u2019s neuromyelitis optica: study of nine cases. Acta Neurol Scand. 2003;108(3):193\u2013200.","journal-title":"Acta Neurol Scand."},{"issue":"5","key":"211_CR52","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1191\/1352458505ms1200cr","volume":"11","author":"AY Poppe","year":"2005","unstructured":"Poppe AY, Lapierre Y, Melan\u00e7on D, et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler. 2005;11(5):617\u201321.","journal-title":"Mult Scler"},{"issue":"8","key":"211_CR53","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.31.8.966","volume":"31","author":"M Berman","year":"1981","unstructured":"Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology. 1981;31(8):966\u201371.","journal-title":"Neurology"},{"issue":"4","key":"211_CR54","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.semarthrit.2008.09.002","volume":"39","author":"G Espinosa","year":"2010","unstructured":"\u2022\u2022 Espinosa G, Mendiz\u00e1bal A, M\u00ednguez S, et al. Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients. Semin Arthritis Rheum. 2010;39(4):246\u201356. Epub 2008 Nov 20. In this study, the main clinical and immunologic features of 22 patients, including 2 previously unreported cases, were compared with a group of 32 SLE patients with transverse myelitis affecting less than 4 spinal segments collected from 3 reported series.","journal-title":"Semin Arthritis Rheum."},{"issue":"1","key":"211_CR55","first-page":"34","volume":"17","author":"C Lavalle","year":"1990","unstructured":"Lavalle C, Pizarro S, Drenkard C, S\u00e1nchez-Guerrero J, Alarc\u00f3n-Segovia D. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol. 1990;17(1):34\u20137.","journal-title":"J Rheumatol"},{"key":"211_CR56","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/ard.59.2.120","volume":"59","author":"B Kovacs","year":"2000","unstructured":"Kovacs B, Lafferty T, Brent L, DeHoratius R. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis. 2000;59:120\u20134.","journal-title":"Ann Rheum Dis"},{"key":"211_CR57","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10067-002-8287-2","volume":"21","author":"Y Sherer","year":"2002","unstructured":"Sherer Y, Hassin S, Shoenfeld Y, et al. Transverse myelitis in patients with antiphospholipid antibodies\u2014the importance of early diagnosis and treatment. Clin Rheumatol. 2002;21:207\u201310.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"211_CR58","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.1986.01050160120026","volume":"104","author":"DA Jabs","year":"1986","unstructured":"Jabs DA, Miller NR, Newman SA, Johnson MA, Stevens MB. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol. 1986;104(4):564\u20138.","journal-title":"Arch Ophthalmol"},{"key":"211_CR59","first-page":"290","volume":"77","author":"A Theodoridou","year":"2006","unstructured":"Theodoridou A, Settas L. Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry. 2006;77:290\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"211_CR60","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/rheumatology\/41.4.470","volume":"41","author":"AN Gibbs","year":"2002","unstructured":"Gibbs AN, Moroney J, Foley-Nolan D, O\u2019Connell PG. Neuromyelitis optica (Devic\u2019s syndrome) in systemic lupus erythematosus: a case report. Rheumatology (Oxford). 2002;41(4):470\u20131.","journal-title":"Rheumatology (Oxford)."},{"key":"211_CR61","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/art.22540","volume":"57","author":"J Birnbaum","year":"2007","unstructured":"Birnbaum J, Kerr D. Devic\u2019s syndrome in a woman with systemic lupus erythematosus: diagnostic and therapeutic implications of testing for the neuromyelitis optica IgG autoantibody. Arthritis Care Res. 2007;57:347\u201351.","journal-title":"Arthritis Care Res"},{"issue":"6","key":"211_CR62","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/01.icu.0000188361.52166.93","volume":"16","author":"MK Mathews","year":"2005","unstructured":"Mathews MK. Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol. 2005;16(6):341\u20135.","journal-title":"Curr Opin Ophthalmol"},{"issue":"7","key":"211_CR63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ncprheum0818","volume":"4","author":"J Birnbaum","year":"2008","unstructured":"Birnbaum J, Kerr D. Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2008;4(7):381\u20136. Epub 2008 May 20.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"211_CR64","first-page":"446","volume":"26","author":"AA Deodhar","year":"1999","unstructured":"Deodhar AA, Hochenedel T, Bennett RM. Longitudinal involvement of the spinal cord in a patient with lupus related transverse myelitis. J Rheumatol. 1999;26:446\u20139.","journal-title":"J Rheumatol"},{"key":"211_CR65","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1191\/096120301701548490","volume":"10","author":"JF Tellez-Zenteno","year":"2001","unstructured":"Tellez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO, et al. Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases. Lupus. 2001;10:851\u20136.","journal-title":"Lupus"},{"key":"211_CR66","first-page":"280","volume":"31","author":"DP D\u2019Cruz","year":"2004","unstructured":"D\u2019Cruz DP, Mellor-Pita S, Joven B, Sanna G, Allanson J, Taylor J, et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol. 2004;31:280\u20135.","journal-title":"J Rheumatol"},{"issue":"1\u20132","key":"211_CR67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0022-510X(02)00043-6","volume":"197","author":"J de Seze","year":"2002","unstructured":"de Seze J, Stojkovic T, Ferriby D, et al. Devic\u2019s neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci. 2002;197(1\u20132):57\u201361.","journal-title":"J Neurol Sci"},{"issue":"6","key":"211_CR68","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1177\/1352458510361740","volume":"16","author":"JH Min","year":"2010","unstructured":"\u2022\u2022 Min JH, Kim SH, Park MS, et al. Brain MRI lesions characteristic of neuromyelitis optica and positive anti-aquaporin 4-antibody may predict longitudinal extensive myelitis and optic neuritis in Sj\u00f6gren\u2019s syndrome. Mult Scler. 2010;16(6):762\u20134. A patient with Sj\u00f6gren\u2019s syndrome had characteristic brain lesions of NMO with high titers of AQP4 antibodies before developing LETM and ON. This case suggests that brain lesions of NMO associated with systemic autoimmune disorders (especially Sj\u00f6gren\u2019s syndrome) have to be included in the spectrum of NMO-related disorders.","journal-title":"Mult Scler"},{"key":"211_CR69","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1177\/0961203310368968","volume":"19","author":"D Squatrito","year":"2010","unstructured":"\u2022 Squatrito D, Colagrande S, Emmi L. Devic\u2019s syndrome and primary APS: a new immunological overlap. Lupus 2010;19:1337\u20139. This case report describes a patient meeting the classification criteria for primary APS and the new diagnostic criteria for NMO. It is important to diagnose NMO syndrome, as both ON and transverse myelitis were also considered neurological complications of APS. NMO-IgG is a new and fundamental test to determine whether immunosuppressant therapy is recommended for such patients.","journal-title":"Lupus"},{"issue":"10","key":"211_CR70","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s10067-009-1232-x","volume":"28","author":"P Mottaghi","year":"2009","unstructured":"\u2022 Mottaghi P, Ashtari F, Karimzadeh H, Seidbonakdar Z, Karimifar M, Salesi M. Devic\u2019s syndrome concomitant with nephritis in a young woman. Clin Rheumatol. 2009;28(10):1239\u201340.Epub 2009 Aug 1. The authors presented the case of a woman with blurred vision and the inability to walk due to acute ON, transverse myelitis, and NMO, an interesting presentation of this syndrome with proteinuria as the first manifestation of SLE.","journal-title":"Clin Rheumatol"},{"issue":"Suppl 4","key":"211_CR71","doi-asserted-by":"publisher","first-page":"S383","DOI":"10.1007\/s10072-004-0348-7","volume":"25","author":"A Protti","year":"2004","unstructured":"Protti A, Erminio C, Piccolo I, Spreafico C, Colombo F, Ghezzi A. An unusual case with relapsing neuromyelitis optica associated with undifferentiated connective tissue disease. Neurol Sci. 2004;25 Suppl 4:S383\u20135.","journal-title":"Neurol Sci"},{"key":"211_CR72","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/WNL.26.11.1066","volume":"26","author":"RS April","year":"1976","unstructured":"April RS, Vansonnenberg E. A case of neuromyelitis optica (Devic\u2019s syndrome) in systemic lupus erythematosus. Clinicopathologic report and review of the literature. Neurology. 1976;26:1066\u201370.","journal-title":"Neurology"},{"key":"211_CR73","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1191\/0961203306lu2265cr","volume":"15","author":"C Jacobi","year":"2006","unstructured":"Jacobi C, Stingele K, Kretz R, Hartmann M, Storch-Hagenlocher B, Breitbart A, et al. Neuromyelitis optica (Devic\u2019s syndrome) as first manifestation of systemic lupus erythematosus. Lupus. 2006;15:107\u20139.","journal-title":"Lupus"},{"key":"211_CR74","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/rheumatology\/keh560","volume":"44","author":"S Ferreira","year":"2005","unstructured":"Ferreira S, Marques P, Carneiro E, D\u2019Cruz D, Gama G. Devic\u2019s syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome. Rheumatology. 2005;44:693\u20135.","journal-title":"Rheumatology"},{"key":"211_CR75","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2169\/internalmedicine.44.998","volume":"44","author":"N Hagiwara","year":"2005","unstructured":"Hagiwara N, Toyoda K, Uwatoko T, Yasumori K, Ibayashi S, Okada Y. Successful high dose glucocorticoid treatment for subacute neuromyelitis optica with systemic lupus erythematosus. Intern Med. 2005;44:998\u20131001.","journal-title":"Intern Med"},{"key":"211_CR76","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1742-2094-5-22","volume":"5","author":"DJ Graber","year":"2008","unstructured":"Graber DJ, Levy M, Kerr D, Wade WF. Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation. 2008;5:22.","journal-title":"J Neuroinflammation."},{"key":"211_CR77","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/1352458507084107","volume":"14","author":"LR Mehta","year":"2008","unstructured":"Mehta LR, Samuelsson MK, Schwid SR, et al. Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome. Mult Scler. 2008;14:425\u20138.","journal-title":"Mult Scler"},{"issue":"6","key":"211_CR78","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/archneur.64.6.899","volume":"64","author":"BG Weinshenker","year":"2007","unstructured":"Weinshenker BG. Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol. 2007;64(6):899\u2013901.","journal-title":"Arch Neurol"},{"issue":"3","key":"211_CR79","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.20770","volume":"59","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006;59(3):566\u20139.","journal-title":"Ann Neurol"},{"issue":"4","key":"211_CR80","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/rheumatology\/keh532","volume":"44","author":"S Ferreira","year":"2005","unstructured":"Ferreira S, D\u2019Cruz DP, Hughes GR. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford). 2005;44(4):434\u201342. Epub 2005 Jan 11.","journal-title":"Rheumatology (Oxford)"},{"key":"211_CR81","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ana.410440408","volume":"44","author":"D Karussis","year":"1998","unstructured":"Karussis D, Leker RR, Ashkenazi A, Abramsky O. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol. 1998;44:629\u201334.","journal-title":"Ann Neurol"},{"key":"211_CR82","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12016-009-8154-x","volume":"38","author":"A Katzav","year":"2010","unstructured":"\u2022\u2022 Katzav A, Shoenfeld Y, Chapman J. The pathogenesis of neural injury in animal models of the antiphospholipid syndrome. Clin Rev Allergy Immunol. 2010;38:196\u2013200. In this article, the authors propose a logical pathway for how experimental APS causes brain dysfunction. The diffuse brain endothelial dysfunction would result in extravasations of serum proteins, including APS-IgG and activated thrombin, which may induce the behavioral changes observed in the APS mice. They collected data from the mouse experimental APS model that support this hypothesis.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"211_CR83","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805\u201315.","journal-title":"Lancet Neurol."},{"issue":"3","key":"211_CR84","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11940-005-0010-6","volume":"7","author":"DM Wingerchuk","year":"2005","unstructured":"Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Treat Options Neurol. 2005;7(3):173\u201382.","journal-title":"Curr Treat Options Neurol."},{"issue":"1","key":"211_CR85","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/1352458506071174","volume":"13","author":"S Watanabe","year":"2007","unstructured":"Watanabe S, Nakashima I, Misu T, et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler. 2007;13(1):128\u201332.","journal-title":"Mult Scler"},{"issue":"1","key":"211_CR86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","volume":"58","author":"M Keegan","year":"2002","unstructured":"Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002;58(1):143\u20136.","journal-title":"Neurology"},{"key":"211_CR87","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","volume":"51","author":"RN Mandler","year":"1998","unstructured":"Mandler RN, Ahmed W, Dencoff JE. Devic\u2019s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998;51:1219\u201320.","journal-title":"Neurology"},{"issue":"7","key":"211_CR88","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/rheumatology\/kei263","volume":"45","author":"F Falcini","year":"2006","unstructured":"Falcini F, Trapani S, Ricci L, Resti M, Simonini G, de Martino M. Sustained improvement of a girl affected with Devic\u2019s disease over 2 years of mycophenolate mofetil treatment. Rheumatology (Oxford). 2006;45(7):913\u20135. Epub 2006 Apr 25.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"211_CR89","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","volume":"66","author":"A Jacob","year":"2009","unstructured":"\u2022\u2022 Jacob A, Matiello M, Weinshenker BG, et al. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol. 2009;66(9):1128\u201333. In this study, the efficacy and safety of mycophenolate mofetil therapy in 24 patients with NMOSDs were evaluated. The authors concluded that mycophenolate is associated with reduction in relapse frequency and stable or reduced disability in patients with NMOSDs.","journal-title":"Arch Neurol"},{"key":"211_CR90","first-page":"39","volume":"2","author":"A Minagar","year":"2000","unstructured":"Minagar A, Sheremata WA. Treatment of Devic\u2019s disease with methotrexate and prednisone. Int J MS Care. 2000;2:39\u201343.","journal-title":"Int J MS Care"},{"issue":"1","key":"211_CR91","first-page":"172","volume":"35","author":"CC Mok","year":"2008","unstructured":"Mok CC, To CH, Mak A, Poon WL. Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica. J Rheumatol. 2008;35(1):172\u20134.","journal-title":"J Rheumatol"},{"issue":"9","key":"211_CR92","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/archneurol.2009.194","volume":"66","author":"S Nasir","year":"2009","unstructured":"\u2022 Nasir S, Kerr DA, Birnbaum J. Nineteen episodes of recurrent myelitis in a woman with neuromyelitis optica and systemic lupus erythematosus. Arch Neurol. 2009;66(9):1160\u20133. Ongoing B-cell stimulation may have led to activation of the cellular arm of the immune system during earlier attacks and contributed to treatment intractability to rituximab during later attacks.","journal-title":"Arch Neurol"},{"issue":"7","key":"211_CR93","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/archneur.63.7.957","volume":"63","author":"B Weinstock-Guttman","year":"2006","unstructured":"Weinstock-Guttman B, Ramanathan M, Lincoff N, et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol. 2006;63(7):957\u201363.","journal-title":"Arch Neurol"},{"key":"211_CR94","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.4049\/jimmunol.136.8.2747","volume":"136","author":"JM Fidler","year":"1986","unstructured":"Fidler JM, DeJoy SQ, Smith III FR, Gibbons Jr JJ. Selective immunomodulation by the antineoplastic agent mitoxantrone, II: nonspecific adherent suppressor cells derived from mitoxantrone-treated mice. J Immunol. 1986;136:2747\u201354.","journal-title":"J Immunol"},{"key":"211_CR95","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","volume":"65","author":"A Jacob","year":"2008","unstructured":"Jacob A, Weinshenker B, Violich I, et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol. 2008;65:1443\u20138.","journal-title":"Arch Neurol"},{"key":"211_CR96","doi-asserted-by":"publisher","first-page":"S 253","DOI":"10.1177\/1352458509106636","volume":"15","author":"HJ Kim","year":"2009","unstructured":"\u2022\u2022 Kim HJ, Kim W, Park MS, et al. B cell depletion therapy using rituximab in neuromyelitis optica spectrum disorders. Mult Scler 2009;15:S 253. Twenty-seven patients with NMO treated prospectively received multiple infusions of rituximab for up to 2 years to assess the safety and efficacy of this agent.","journal-title":"Mult Scler"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0211-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-011-0211-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0211-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0211-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:46:10Z","timestamp":1684863970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-011-0211-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,16]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["211"],"URL":"https:\/\/doi.org\/10.1007\/s11926-011-0211-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,16]]},"assertion":[{"value":"16 September 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}